Photodynamic therapy with talaporfin sodium induces dose- and time-dependent apoptotic cell death in malignant meningioma HKBMM cells.


Journal

Photodiagnosis and photodynamic therapy
ISSN: 1873-1597
Titre abrégé: Photodiagnosis Photodyn Ther
Pays: Netherlands
ID NLM: 101226123

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 05 06 2018
revised: 27 10 2018
accepted: 29 10 2018
pubmed: 6 11 2018
medline: 18 12 2019
entrez: 4 11 2018
Statut: ppublish

Résumé

To investigate the effect of photodynamic therapy (PDT) with the talaporfin sodium (mono-L-asparthyl chlorine e6: NPe-6) on human malignant meningioma cell line HKBMM cells in vitro. After incubation with NPe6 for 4 h, cells underwent PDT (diode laser irradiation: 3.4 mW/cm In human malignant meningioma HKBMM cells, viability showed a dose- and time-dependent decrease. After 24 h of laser irradiation, NPe6 at 20 μg/ml or more induced a significant decrease in cell viability in both HKBMM cells and KMY-J cells, although they more resistance than the malignant glioma cell line U251 cells. Two kinds of morphological change were also observed in the HKBMM cells, shrinkage of the cell body, indicating apoptosis, and swelling of the cell body, indicating necrosis. In addition, both caspase-3 activity and DNA fragmentation, biochemical markers indicative of apoptosis, showed a dose-dependent increase. The percentage of necrotic cells showing positive staining for annexin V or PI was greater than that of apoptotic cells at a high concentration of NPe6. Lactate dehydrogenase leakage, a biochemical marker of necrosis, also showed a marked increase at a high concentration of NPe6. Photodynamic therapy with NPe6 induced dose- and time-dependent apoptosis in human malignant meningioma HKBMM cells. At a high concentration of NPe6, however, it induced necrosis.

Identifiants

pubmed: 30389626
pii: S1572-1000(18)30187-X
doi: 10.1016/j.pdpdt.2018.10.022
pii:
doi:

Substances chimiques

Annexin A5 0
Photosensitizing Agents 0
Porphyrins 0
Caspase 3 EC 3.4.22.-
Talaporfin P4ROX5ELT2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-34

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Megumi Ichikawa (M)

Department of Neurosurgery, Tokyo Medical University, Tokyo, Japan.

Jiro Akimoto (J)

Department of Neurosurgery, Tokyo Medical University, Tokyo, Japan. Electronic address: jiroaki@gmail.com.

Yuichi Miki (Y)

Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Jun Maeda (J)

Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Tsutomu Takahashi (T)

Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Yasuyuki Fujiwara (Y)

Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Michihiro Kohno (M)

Department of Neurosurgery, Tokyo Medical University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH